The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Juelsgaard Stephen G since 2006.
The trader's CIK number is 1214125.
At the time of the last reporting, Juelsgaard Stephen G was the EVP, CCO & Secretary of Genentech Inc. (stock ticker symbol DNA).
Also see all insider trading activities at Genentech Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2008 | DNA | 0 | $0 | 111,220 | $8,748,892 | 111,220 | $4,611,905 |
2007 | DNA | 0 | $0 | 100,000 | $8,098,122 | 100,000 | $2,799,785 |
2006 | DNA | 0 | $0 | 20,000 | $1,640,201 | 20,000 | $285,600 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2008-07-18 | DNA | Option Ex | 4,300 | 42.05 | 180,815 |
2008-07-18 | DNA | Sale | 4,300 | 81.99 | 352,548 |
2008-07-18 | DNA | Option Ex | 20,700 | 42.05 | 870,434 |
2008-07-18 | DNA | Sale | 20,700 | 82.10 | 1,699,511 |
2008-07-16 | DNA | Sale | 8,366 | 79.35 | 663,867 |
2008-07-16 | DNA | Option Ex | 8,366 | 42.05 | 351,790 |
2008-07-16 | DNA | Sale | 16,634 | 79.30 | 1,319,026 |
2008-07-16 | DNA | Option Ex | 16,634 | 42.05 | 699,459 |
2008-02-27 | DNA | Option Ex | 61,220 | 40.99 | 2,509,407 |
2008-02-27 | DNA | Sale | 61,220 | 77.00 | 4,713,940 |
2007-11-09 | DNA | Option Ex | 50,000 | 40.99 | 2,049,500 |
2007-11-09 | DNA | Sale | 50,000 | 75.03 | 3,751,550 |
2007-01-12 | DNA | Sale | 20,385 | 87.14 | 1,776,348 |
2007-01-12 | DNA | Option Ex | 1,215 | 14.28 | 17,350 |
2007-01-12 | DNA | Sale | 1,215 | 86.55 | 105,152 |
2007-01-12 | DNA | Option Ex | 10,600 | 14.28 | 151,368 |
2007-01-12 | DNA | Sale | 10,600 | 86.71 | 919,125 |
2007-01-12 | DNA | Option Ex | 17,800 | 14.28 | 254,184 |
2007-01-12 | DNA | Sale | 17,800 | 86.85 | 1,545,947 |
2007-01-12 | DNA | Option Ex | 20,385 | 16.06 | 327,383 |
2006-08-18 | DNA | Option Ex | 14,800 | 14.28 | 211,344 |
2006-08-18 | DNA | Sale | 14,800 | 82.07 | 1,214,576 |
2006-08-18 | DNA | Option Ex | 5,200 | 14.28 | 74,256 |
2006-08-18 | DNA | Sale | 5,200 | 81.85 | 425,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Juelsgaard Stephen G (EVP, CCO & Secretary of Genentech Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.